1. P-139Chemotherapy rechallenge or reintroduction, regorafenib, and TAS-102 for metastatic pretreated colorectal cancer patients: a propensity score analysis of treatment beyond the second line (PROSERpINA Study). (2nd July 2019) Authors: Calegari, M; Zurlo, I; Basso, M; Orlandi, A; Bensi, M; Camarda, F; Stefano, B Di; Vivolo, R; Pozzo, C; Sperduti, I; Bria, E; Salvatore, L; Tortora, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-317Clinical, pathological, and prognostic features of rare BRAF mutations in metastatic colorectal cancer: a bi-institutional retrospective analysis (REBUS study). (2nd July 2019) Authors: Bensi, M; Calegari, M; Basso, M; Orlandi, A; Boccaccino, A; Lombardo, F; Zurlo, I; Stefano, B Di; Camarda, F; Vivolo, R; Cocomazzi, A; Martini, M; Auriemma, A; Pozzo, C; Bria, E; Salvatore, L; Tortora, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗